Quality of life associated with acute and chronic graft-versus-host disease.
about
Tacrolimus versus cyclosporine A for prevention of graft versus host disease after stem cell transplantationTacrolimus versus cyclosporine A for prevention of graft versus host disease after stem cell transplantationPhysical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patientsNational Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group ReportTrajectories of Quality of Life after Hematopoietic Cell Transplantation: Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network 0902 Data.Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention.Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concernsDeterminants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD ConsortiumChronic graft-versus-host disease (GVHD) in children.Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies.Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignanciesThe pathophysiology of chronic graft-versus-host disease: the unveiling of an enigmaSensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium.Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease.Changing factors associated with parent activation after pediatric hematopoietic stem cell transplant.A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantationHealth-related quality of life following allogeneic hematopoietic stem cell transplantation.Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation.Addressing parenting concerns of bone marrow transplant patients: opening (and closing) Pandora's box.Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature.Quality of life concerns and depression among hematopoietic stem cell transplant survivors.Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinionImmune modulation and chronic graft-versus-host disease.Quality of life after allogeneic hematopoietic cell transplantation.Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.Long-term health related quality of life following intensive care during treatment for haematological malignancies.Quality of life associated with sirolimus for prevention of graft-versus-host disease: results from a randomized trial.A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood.Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD.The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature.Management of faecal incontinence in graft-versus-host disease.
P2860
Q24235827-439B99D2-7DD4-426D-BC10-A70DE510EACDQ26472072-5268FAA9-DBEB-4579-AC32-F9DDB46AE3DAQ26787230-4C03A266-B3A7-4AF5-B7B0-1C4B2EA0DB58Q26827651-4CDF976D-CBF7-454F-8BDD-5305AC54B699Q31122330-8A991132-677A-481E-8718-6E38BA9AF1B6Q33606151-66777E47-31AA-489B-B4D6-F68D78F9F92BQ33754654-DA1EADED-8673-4ED4-A0FC-8320D992D0FEQ33774650-9E92BA7B-C12E-484D-ABCE-58F0AE6DD073Q33830644-3A2CBD39-8E74-484B-9AD8-836E8E9D7633Q33857680-CD503152-52EC-4213-A778-4ECE1AEC8B26Q33944262-C6AB0293-5993-42D8-8C91-8E8AFCE3487BQ33949546-5FB3008E-B94E-4260-894C-CFC79B2994D3Q33965200-3D97A2DA-36F7-4185-89D4-6A07C6B0AE56Q35084404-04BA4D4C-4D1C-4BA7-A337-65CCE883AC40Q35266002-0FAFABBA-CE20-4D12-A13C-8450A70B7086Q35571058-BAE70B9C-9E89-4C20-B594-12846A0466B1Q35667530-9457707B-055A-446D-B184-261A62A6FE32Q35865095-15551BE4-75F9-4AE6-AAC9-614B98268530Q35958194-4083D2F4-0D29-4C95-AB21-D4769F0E5EB0Q36186850-3E9024EE-4569-4DA7-ABE1-57FBCFB86B5FQ36286379-59307551-BAC1-4ADE-9CA5-0EBBCE8592A2Q36443116-33E0CB18-E4C8-44AC-A383-A0D7162AD90EQ36503766-285F0467-A776-40B4-82B4-C34629EDEB22Q36578771-7F971B1F-A768-4826-9E88-D68A139877C1Q36623642-DDD4AC75-1D63-498B-AC38-E77B8F151217Q36707816-A67B58D2-603C-44B9-893A-3E0B5D8DBACBQ36712018-AC353CA3-5F60-466A-8392-4AA9335807C4Q36746364-086C45EA-627F-437E-8779-44BBB572B99FQ37141324-15985157-D3EA-47FA-BBCC-0B34B0585741Q37154179-B25B8B8B-6D3D-4538-A3F0-B9B46E4F0558Q37251057-B239408F-5330-405F-A229-B0319BE66BDEQ37262503-1706B130-4957-40F7-A16B-0CBB2C4C0D89Q37334978-7F496284-4D41-47DE-B00A-95A0128614D0Q37539193-7A313DBA-7DAC-484E-AB40-4D05CD8E5381Q37618931-628ED9AF-F547-4B5A-974B-F3C9495A712BQ37692018-9C71A80C-7D78-4647-9540-C4AFF6387949Q37724580-4A0F655C-FC9B-49D4-9C05-B24FF8CC2890Q37861866-F659E1B4-E2C0-46A4-AF72-548DFD34F418Q37923304-001239B2-3DA3-4E4F-9D20-B44D83AC497CQ37981505-24159A33-28C7-4AD6-A1AB-D2780586A2D8
P2860
Quality of life associated with acute and chronic graft-versus-host disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Quality of life associated with acute and chronic graft-versus-host disease.
@en
Quality of life associated with acute and chronic graft-versus-host disease.
@nl
type
label
Quality of life associated with acute and chronic graft-versus-host disease.
@en
Quality of life associated with acute and chronic graft-versus-host disease.
@nl
prefLabel
Quality of life associated with acute and chronic graft-versus-host disease.
@en
Quality of life associated with acute and chronic graft-versus-host disease.
@nl
P2093
P356
P1476
Quality of life associated with acute and chronic graft-versus-host disease.
@en
P2093
Soiffer RJ
P2888
P304
P356
10.1038/SJ.BMT.1705434
P407
P577
2006-07-03T00:00:00Z